Clinical Trials

Showing   of 56 results

Clinical trials team in front of UHCMC

Clinical Trials Awareness Week 2022 Celebrates Those That Make Medical Breakthroughs Possible

Clinical Trials Awareness Week is a week-long celebration recognizing our research investigators, study team members and research participants and their commitment to advancing science and discovery in medicine. All of whom have contributed to...

Select2 Clinical Trial scan image for Innovations Summer 2022 article

Global SELECT2 Clinical Trial Studies Endovascular Thrombectomy in Large Core Infarct Patients

Innovations in Neurology & Neurosurgery | Summer 2022

Confused brain illustrative of dementia alzheimer

New Alzheimer’s Disease Study Seeks Northeast Ohio Volunteers with Down Syndrome

UH Clinical Update | April 2022

UH Seidman Cancer Center to Launch First-Ever Trial of NK Therapy and Vactosertib in Treating Colorectal Cancer and Hematological Malignancies

Trial employs new method of expanding and activating universal donor NK cells developed in Cleveland - Innovations in Cancer | Winter 2022

Pancreas cancer illustration

Expanded Neuroendocrine Tumor Team at UH Seidman Cancer Center Boosts Access to Clinical Trials

Trials of promising anti-angiogenesis therapies under way here - Innovations in Cancer | Winter 2022

Prostate Cancer 3D illustration

Researchers Show Increased Survival Rate in Prostate Cancer Patients with Addition of Hormone Therapy Treatments

First-of-its-kind meta-analysis published in The Lancet Oncology - Innovations in Cancer Winter 2022

CRC Mobile Unit

Bringing Clinical Research Closer to Home

UH Research & Education Update | January 2022

Ankit Mangla, MD

Trials Testing PEGylated Interleukins Against Advanced Melanoma Under Way at UH Seidman Cancer Center

Novel agents thought to preserve interleukin’s ability to boost T cell growth and fight cancer, without harmful side effects associated with high-dose interleukin - Innovations in Cancer | Fall 2021

Results are loading...